A detailed history of State Of Alaska, Department Of Revenue transactions in Regenxbio Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 25,948 shares of RGNX stock, worth $201,615. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,948
Previous 26,605 2.47%
Holding current value
$201,615
Previous $311,000 12.54%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$10.49 - $14.39 $6,891 - $9,454
-657 Reduced 2.47%
25,948 $272,000
Q2 2024

Aug 05, 2024

BUY
$11.51 - $21.53 $22,432 - $41,961
1,949 Added 7.9%
26,605 $311,000
Q1 2024

Apr 19, 2024

SELL
$12.17 - $24.61 $2,957 - $5,980
-243 Reduced 0.98%
24,656 $519,000
Q4 2023

Jan 19, 2024

SELL
$12.89 - $20.82 $3,622 - $5,850
-281 Reduced 1.12%
24,899 $446,000
Q3 2023

Oct 16, 2023

BUY
$16.46 - $19.99 $4,905 - $5,957
298 Added 1.2%
25,180 $414,000
Q2 2023

Jul 24, 2023

SELL
$17.23 - $21.71 $15,696 - $19,777
-911 Reduced 3.53%
24,882 $497,000
Q1 2023

Apr 17, 2023

SELL
$18.08 - $24.55 $7,846 - $10,654
-434 Reduced 1.65%
25,793 $487,000
Q4 2022

Jan 11, 2023

BUY
$20.4 - $24.73 $3,835 - $4,649
188 Added 0.72%
26,227 $594,000
Q3 2022

Oct 20, 2022

SELL
$22.29 - $35.04 $57,017 - $89,632
-2,558 Reduced 8.94%
26,039 $688,000
Q2 2022

Jul 08, 2022

BUY
$19.35 - $35.04 $46,827 - $84,796
2,420 Added 9.24%
28,597 $706,000
Q1 2022

Apr 14, 2022

SELL
$24.62 - $34.31 $11,694 - $16,297
-475 Reduced 1.78%
26,177 $868,000
Q4 2021

Jan 12, 2022

SELL
$30.19 - $40.28 $20,982 - $27,994
-695 Reduced 2.54%
26,652 $871,000
Q3 2021

Oct 07, 2021

BUY
$29.09 - $45.68 $93,844 - $147,363
3,226 Added 13.37%
27,347 $1.15 Million
Q2 2021

Jul 12, 2021

BUY
$32.46 - $40.48 $17,041 - $21,252
525 Added 2.22%
24,121 $937,000
Q1 2021

Apr 09, 2021

BUY
$33.61 - $49.95 $10,419 - $15,484
310 Added 1.33%
23,596 $804,000
Q4 2020

Jan 08, 2021

SELL
$26.52 - $49.35 $120,082 - $223,456
-4,528 Reduced 16.28%
23,286 $1.06 Million
Q3 2020

Oct 05, 2020

SELL
$27.01 - $40.26 $55,100 - $82,130
-2,040 Reduced 6.83%
27,814 $765,000
Q2 2020

Jul 06, 2020

BUY
$27.75 - $43.44 $24,420 - $38,227
880 Added 3.04%
29,854 $1.1 Million
Q1 2020

Apr 06, 2020

BUY
$21.5 - $54.2 $114,165 - $287,802
5,310 Added 22.44%
28,974 $938,000
Q4 2019

Jan 07, 2020

SELL
$34.54 - $44.87 $12,917 - $16,781
-374 Reduced 1.56%
23,664 $969,000
Q3 2019

Oct 02, 2019

BUY
$31.84 - $50.88 $431,877 - $690,136
13,564 Added 129.5%
24,038 $855,000
Q2 2019

Jul 23, 2019

BUY
$42.0 - $59.29 $6,888 - $9,723
164 Added 1.59%
10,474 $538,000
Q1 2019

Apr 09, 2019

BUY
$40.82 - $62.45 $10,000 - $15,300
245 Added 2.43%
10,310 $590,000
Q4 2018

Jan 10, 2019

BUY
$39.11 - $75.15 $18,577 - $35,696
475 Added 4.95%
10,065 $422,000
Q3 2018

Oct 09, 2018

BUY
$65.0 - $82.15 $53,300 - $67,363
820 Added 9.35%
9,590 $724,000
Q2 2018

Jul 10, 2018

BUY
$27.2 - $74.35 $238,544 - $652,049
8,770 New
8,770 $629,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $336M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.